Skip to main content
SpringerLink
Log in

Idiopathische thrombozytopenische Purpura

  • Chapter
Pädiatrische Hämatologie und Onkologie

Zusammenfassung

Die Ursache der idiopathischen thrombozytopenischen Purpura (ITP) ist noch weitgehend unbekannt. Die Pathophysiologie ist (auto-)immunologisch. Erkenntnisse der veränderten Kaskade der Immunantwort führten zu modernen biologischen Therapieansätzen. Prospektive kooperative Studien zeigen neue Aspekte der Demographie, des Verlaufs und der Betreuung bzw. Behandlung von Kindern mit ITP auf.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 34.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ahn YS, Harrington WJ, Seelman RC et al (1974) Vincristine therapy of idiopathic and secondary thrombocytopenias. N Engl J Med 291:376

    Article  PubMed  CAS  Google Scholar 

  • Andersen JC (1994) Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose demamethasone therapy. N Engl J Med 330:1560–1564

    Article  PubMed  CAS  Google Scholar 

  • Andrew M, Blanchette V, Adams M et al (1991) A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. J Pediatr 120:522–527

    Google Scholar 

  • Aronis S, Platokouki H, Mitsika A et al (1995) Treatment of chronic idopathic thrombocytopenic purpura. Pediatr Hematol Oncol 12:409–410

    Google Scholar 

  • Balint J, Quagliata F, Cochran SK et al (1995) Association of anti-platelet IgG antibody levels with response to extracorporeal protein A/silica Immunoadsorption in ITP patients. Am J of Hematol 50:74–75

    Google Scholar 

  • Blanchette V, Imbach P, Andrew M et al (1994) Randomized trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 344:703

    Article  PubMed  CAS  ISI  Google Scholar 

  • Blanchette V, Luke B, Anrew M et al (1993) A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 123:989

    PubMed  CAS  Google Scholar 

  • Brighton TA, Evans S, Castaldi PA et al (1996) Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood 88:194–201

    PubMed  CAS  ISI  Google Scholar 

  • Buchanan GR, Holtkamp CA (1984) Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial. Am J Pediatr Hematol Oncol 6:355

    PubMed  CAS  Google Scholar 

  • Bussel JB, Graziano JN, Kimberly RP et al (1991) Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity, and mechanism of effect. Blood 77:1884

    PubMed  CAS  ISI  Google Scholar 

  • Bussel JB, Saal S, Gordon B (1988) Combined plasma exchange and intravenous gammaglobulin in the treatment of patients with refractory immune thrombocytopenic purpura. Transfusion 28:38

    Article  PubMed  CAS  ISI  Google Scholar 

  • Centers for Disease Control and Prevention (1994) Outbreak of hepatitis C associated with intravenous immunoglobulin administration — United States, October 1993–June 1994. Morb Mortal Wkly Rep 43:505

    Google Scholar 

  • Davis PW, Williams DA, Shamberger RC (1991) Immune thrombocytopenia: Surgical therapy and predictors of response. J Pediatr Surg 26:407

    PubMed  CAS  Google Scholar 

  • Dietrich S, Kaverl SV, Kazatchkine MD (1992) Modulation of autoimmunity by intravenous globulin through interaction with the functions of the immune/idiotypic network. Clin Immunol Immunopathol 62:873–881

    Article  Google Scholar 

  • Dubbeld P, Hillen HFP, Schouten HC (1994) Interferon treatment of refractory idiopathic thrombocytopenic purpura (ITP). Eur J Haematol 52:233

    PubMed  CAS  Google Scholar 

  • Duhem C, Dicato MA, Ries F (1994) Side-effects of intravenous immune globulins. Clin Exp Immunol 97:79

    PubMed  Google Scholar 

  • Emilia G, Morselli M, Luppi M et al (2002) Long-term salvage therapy with cyclosporin in refractory idiopathic thrombocytopenic purpura. Blood 99:1482–1485

    Article  PubMed  CAS  ISI  Google Scholar 

  • Emmons RVB, Reid DM, Cohen RL et al (1996) Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 87:4068–4071

    PubMed  CAS  ISI  Google Scholar 

  • Facon T, Caulier MT, Wattel E et al (1994) A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: A report on 42 patients. Br J Haematol 86:678

    PubMed  CAS  Google Scholar 

  • Flores A, Carles J, Junca J et al (1990) Danazol therapy in chronic immune thrombocytopenic purpura. Eur J Haematol 45:109

    PubMed  CAS  Google Scholar 

  • Gaines AR (2000) Acute onset hemoglobinemia and/or hemogloinuria and sequelae following Rho(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood 95:2523–2529

    PubMed  CAS  ISI  Google Scholar 

  • George JN, Woolf SH, Raskob GE et al (1996) Idiopathic thrombocytopenic purpura; A practice guidline developed by explicit methods for the American Society of Hematology. Blood 88:3–40

    PubMed  CAS  ISI  Google Scholar 

  • Halperin DS, Doyle JJ (1988) Is bone marrow examination justified in idiopathic thrombocytopenic purpura? Am J Dis Child 142:509

    Google Scholar 

  • Harrington WJ, Minnich V, Hollingsworth JW et al (1951) Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 38:1–10

    PubMed  CAS  Google Scholar 

  • Heyns AP, Lotter MG, Badenhorst PN et al (1982) Kinetics and sites of destruction of 111-indium-oxine-labeled platelets in idiopathic thrombocytopenic purpura: a quantitative study. Am J Haematol 12:167–177

    CAS  Google Scholar 

  • Hudson JG, Yates P, Scott GL (1992) Further concern over use of alpha-interferon in immune thrombocytopenic purpura. Br J Haematol 82:630

    PubMed  CAS  Google Scholar 

  • Huhn RD, Read EJ, Rick M et al (1999) Intensive immunosuppression with high-dose cyclophosphamide and autologous CD34+ selected hematopoietic cell support for chronic refractory autoimmune thrombocytopenia (abstract). Blood 94:178

    Google Scholar 

  • Imbach P (2003) Refractory idiopathic immune thrombocytopenic purpura in children — current and future treatment options. Ped Drugs 5:795–801

    Google Scholar 

  • Imbach P, Akatsuka J, Blanchette V et al (1995) Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity. Eur J Pediatr 154(3):60–64

    Google Scholar 

  • Imbach P, Barandun S, D’Apuzzo V et al (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1:1228–1231

    PubMed  CAS  ISI  Google Scholar 

  • Imbach P, Kühne T, Holländer G (1997) Immunologic aspects in pathogenesis and treatment of immune thrombocytopenic purpura (ITP) in children. Current Opinion Pediatr 9:35–40

    CAS  Google Scholar 

  • Imbach P, Kühne T, Signer E (2002) Historical aspects and present knowledge of idiopathic thrombocytopenic purpura. Br J Haemat 119:894–900

    Article  Google Scholar 

  • Imbach P, Luginbühl L, Späth P et al (1985) Cyclosporin A (CyA) and intravenous immunoglobulin (i.v. IgG) in chronic immune thrombocytopenic purpura (ITP) in childhood: a clinical and immunological study (progress report). In: Schindler R (ed) Cyclosporin in autoimmune disease,pp 268–269. Springer, Berlin Heidelberg

    Google Scholar 

  • Imholz B, Imbach P, Baumgartner C et al (1988) Intravenous immunoglobulin (i.v. IgG) for previously treated acute or for chronic idiopathic thrombocytopenic purpura (ITP) in childhood: A prospective multicenter study. Blut 56: 63

    Article  PubMed  CAS  ISI  Google Scholar 

  • Karpatkin S, Fotino M, Winchester R (1981) Hereditiy autoimmune thrombocytopenic purpura: an immunologic and genetic study. Ann Intern Med 94:781–782

    PubMed  CAS  Google Scholar 

  • Kattamis AC, Shankar S, Cohen AR (1997) Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G. J Pediatr 130:281–283

    PubMed  CAS  Google Scholar 

  • Kiefel V, Santoso S, Weisheit M et al (1987) Monolocal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 70:1722–1726

    PubMed  CAS  ISI  Google Scholar 

  • Kühne T, Freedman J, Semple JW et al (1997) Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenoc purpura. Pediatr 130:17–24

    Google Scholar 

  • Kühne T, Imbach P, Bolton-Maggs PHB et al for the Intercontinental Childhood ITP Study Group (2001) Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet 358: 2122–2125

    PubMed  Google Scholar 

  • Laster AJ, Conley CL, Kickler TS et al (1982) Chronic immune thrombocytopenic purpura in monozygotic twins: genetic factos predisposing to immune thrombocytopenic purpura. N Engl J Med 307:1495–1498

    Article  PubMed  CAS  Google Scholar 

  • Lilleyman JS (1994) Intracranial hemorrhage in idiopathic thrombocytopenic purpura. Arch Dis Child 71: 251–253

    PubMed  CAS  Google Scholar 

  • Marder VJ, Nusbacher J, Anderson FW (1981) One-year follow-up of plasma exchange therapy in 14 patients with idiopathic thrombocytopenic purpura. Transfusion 21:291

    Article  PubMed  CAS  ISI  Google Scholar 

  • Matthey F, Ardeman S, Jones L et al (1990) Bleeding in immune thrombocytopenic purpura after alpha-interferon. Lancet 335:471

    Article  PubMed  CAS  ISI  Google Scholar 

  • McMillan R, Tani P, Millard F et al (1987) Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 70:1040–1045

    PubMed  CAS  ISI  Google Scholar 

  • Ozsoylu S, Irken G, Karabent A (1989) High-dose intravenous methyl-prednisolone for acute childhood idiopathic thrombocytopenic purpura. Eur J Haematol 42:431

    PubMed  CAS  Google Scholar 

  • Proctor SJ, Jackson G, Carey P et al (1989) Improvement of platelet counts in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon. Blood 74: 1894–1897

    PubMed  CAS  ISI  Google Scholar 

  • Quiquandon I, Fenaux P, Caulier MT et al (1990) Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: A report on 53 cases. Br J Haematol 74:223

    PubMed  CAS  Google Scholar 

  • Raife TJ, Olson JD, Lentz SR (1996) Platelet antibody testing in idiopathic thrombocytopenic purpura. Blood 89:1112–1114

    ISI  Google Scholar 

  • Reiner A, Gernsheimer T, Slichter SJ (1995) Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura. Blood 85:351

    PubMed  CAS  ISI  Google Scholar 

  • Robb LG, Tiedeman K (1990) Idiopathic thrombocytopenic purpura: Predictors of chronic disease. Arch Dis Child 65:502

    Article  PubMed  CAS  Google Scholar 

  • Salama A, Kiefel V, Mueller-Eckhardt C (1986) Effect of IgG anti Rho(D) in adult patients with chronic autoimmune thrombocytopenia. Am J Hematol 22:241–250

    PubMed  CAS  Google Scholar 

  • Saleh MN, Gutheil J, Moore M et al (2000) A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia. Semin Oncol 6(suppl 12):99–103

    Google Scholar 

  • Samuelson A, Towers TL, Ravetch JV (2001) Anti-inflamatory Activity of IVIG Mediated Through the Inhibitory FC Receptor. Science 291:484–486

    Google Scholar 

  • Sartorius JA (1984) Steroid treatment of idiopathic thrombocytopenic purpura in children. Preliminary results of a randomized cooperative study. Am J Pediatr Hematol Oncol 6:165

    Article  PubMed  CAS  Google Scholar 

  • Semple JW, Milev Y, Cosgrave D et al (1996) Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: Relationship to platelet phenotype and antiplatelet T-Cell reactivity. Blood 87: 4245–4254

    PubMed  CAS  ISI  Google Scholar 

  • Stasi R, Pagana A, Stipa E et al (2001) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 98:952–957

    Article  PubMed  CAS  ISI  Google Scholar 

  • Semple JW, Freedman J (1995) Abnormal cellular immune mechanisms associated with autoimmune thrombocytopenia. Trans Med Reviews 4:327–338

    Google Scholar 

  • Styrt B (1990) Infection associated with asplenia: Risks, mechanisms, and prevention. Am J Med 88:5–33

    Google Scholar 

  • Tamary H, Kaplinsky C, Levy I et al (1994) Chronic childhood idiopathic thrombocytopenic purpura; Longterm follow-up. Acta Paediatr 83:931

    PubMed  CAS  ISI  Google Scholar 

  • Van der Beek-Boter JW, Van Oers MHJ, Von dem Borne AEKG et al (1992) Ascorbate for the treatment of ITP. Eur J Haematol 48:61

    PubMed  Google Scholar 

  • Van Leeuwen EF, van der Ven JTH, Engelfriet CP et al (1982) Specificity of autoantibodies in autoimmune thrombocytopenia. Blood 59:23–26

    PubMed  Google Scholar 

  • Warner MN, Moore JC, Warkentin TE et al (1999) A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura. Br J Haemat 104:442–447

    Article  CAS  Google Scholar 

  • Weinblatt ME, Kochen J, Ortega J (1988) Danazol for children with immune thrombocytopenic purpura. Am J Dis Child 142:1317

    PubMed  CAS  Google Scholar 

  • Yu MW, Mason BL, Guo ZP et al (1995) Hepatitis C transmission associated with intravenous immunoglobulins. Lancet 345:1173

    Article  PubMed  CAS  ISI  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abt. Pädiatrische Onkologie/Hämatologie, Universitäts-Kinderspital bei der Basel UKBB, Römergasse 8, 4005, Basel, Schweiz

    Prof. Dr. Paul Imbach & PD. Dr. Thomas Kühne

  2. Otto-Heubner-Centrum für Kinder- und Jugendmedizin Klinik für Allgemeine Pädiatrie und Knochenmarktransplantation, Charité Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin

    Prof. Dr. Gerhard Gaedicke

Authors
  1. Prof. Dr. Paul Imbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. PD. Dr. Thomas Kühne
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. Gerhard Gaedicke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Forschungsinstitut für krebskranke Kinder, St. Anna Kinderspital, Kinderspitalgasse 6, 1090, Wien, Österreich

    Helmut Gadner

  2. Klinik für Allgemeine Pädiatrie und Knochenmarktransplantation, Charité Campus Virchow-Klinikum Otto-Heubner-Centrum für Kinder- und Jugendmedizin, Augustenburger Platz 1, 13353, Berlin

    Gerhard Gaedicke

  3. Zentrum für Kinderheilkunde und Jugendmedizin, Universitätsklinikum Freiburg, Mathildenstr. 1, 79106, Freiburg

    Charlotte Niemeyer

  4. Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum Münster, Albert-Schweitzer-Str. 33, 48129, Münster

    Jörg Ritter

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Imbach, P., Kühne, T., Gaedicke, G. (2006). Idiopathische thrombozytopenische Purpura. In: Gadner, H., Gaedicke, G., Niemeyer, C., Ritter, J. (eds) Pädiatrische Hämatologie und Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29036-2_35

Download citation

  • DOI: https://doi.org/10.1007/3-540-29036-2_35

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-03702-6

  • Online ISBN: 978-3-540-29036-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation